We are live on
!
Find out more
Mirae Asset Global Investments Portfolio holdings
AUM
$67.7B
1-Year Est. Return
57.61%
This Fund
S&P 500
This Quarter
Est. Return
+4.39%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$36B
AUM Growth
+$4.16B
(+13%)
Cap. Flow
+$3.25B
Cap. Flow
% of AUM
9.02%
Top 10 Holdings %
Top 10 Hldgs %
37.04%
Holding
1,767
New
125
Increased
1,085
Reduced
387
Closed
124
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$315M |
| 2 |
Apple
AAPL
|
+$187M |
| 3 |
Microsoft
MSFT
|
+$171M |
| 4 |
Meta Platforms (Facebook)
META
|
+$118M |
| 5 |
Tesla
TSLA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$61.1M |
| 2 |
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
|
+$51.8M |
| 3 |
Invesco Aerospace & Defense ETF
PPA
|
+$38.3M |
| 4 |
Schwab US Dividend Equity ETF
SCHD
|
+$37.5M |
| 5 |
Invesco S&P 500 Momentum ETF
SPMO
|
+$36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.91% |
| 2 | Communication Services | 10.86% |
| 3 | Consumer Discretionary | 9.43% |
| 4 | Healthcare | 6.67% |
| 5 | Financials | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Acadia Realty Trust
AKR
$2.84B
| $78.6K | ﹤0.01% |
3,829
+960
| +33% | +$19.1K |
|
1302
Coursera
COUR
$1.48B
| $78.1K | ﹤0.01% |
10,610
-9,206
| -46% | -$80.2K |
|
1303
Alvotech
ALVO
$1.36B
| $78K | ﹤0.01% |
15,211
+3,110
| +26% | +$19.6K |
|
1304
Trevi Therapeutics
TRVI
$2.53B
| $78K | ﹤0.01% |
6,231
+1,523
| +32% | +$17.6K |
|
1305
Fortrea Holdings
FTRE
$1.74B
| $77.5K | ﹤0.01% |
4,490
+980
| +28% | +$12.1K |
|
1306
Agios Pharmaceuticals
AGIO
$2.04B
| $77.1K | ﹤0.01% |
2,834
+588
| +26% | +$20.6K |
|
1307
iShares 20+ Year Treasury Bond BuyWrite Strategy ETF
TLTW
$1.83B
| $77.1K | ﹤0.01% |
3,400
| – | – |
|
1308
Mercury Systems
MRCY
$6.7B
| $76.8K | ﹤0.01% |
1,052
-253
| -19% | -$18.8K |
|
1309
LiveRamp
RAMP
$2.3B
| $76.5K | ﹤0.01% |
2,606
-8,111
| -76% | -$233K |
|
1310
VEON
VEON
$3.92B
| $75.7K | ﹤0.01% |
1,440
| – | – |
|
1311
Pilgrim's Pride
PPC
$6.4B
| $75.1K | ﹤0.01% |
1,927
-1,075
| -36% | -$41.3K |
|
|
MPT
1312
Medical Properties Trust
MPT
$2.42B
| $74.9K | ﹤0.01% |
14,984
+3,746
| +33% | +$19.5K |
|
1313
e.l.f. Beauty
ELF
$5.47B
| $74.2K | ﹤0.01% |
976
-778
| -44% | -$76.6K |
|
1314
Immunocore
IMCR
$1.77B
| $73.6K | ﹤0.01% |
2,120
+572
| +37% | +$20.2K |
|
1315
EyePoint Inc
EYPT
$1.17B
| $73.5K | ﹤0.01% |
4,023
+1,358
| +51% | +$19.2K |
|
1316
Taysha Gene Therapies
TSHA
$2.05B
| $73.2K | ﹤0.01% |
13,311
+2,765
| +26% | +$13.4K |
|
|
NOAH
1317
Noah Holdings
NOAH
$588M
| $73.1K | ﹤0.01% |
7,285
| – | – |
|
1318
DT Midstream
DTM
$13.9B
| $73K | ﹤0.01% |
+610
| New | +$70.1K |
|
1319
Innoviva
INVA
$1.5B
| $72.6K | ﹤0.01% |
3,633
+1,197
| +49% | +$23.4K |
|
1320
uniQure
QURE
$3.13B
| $72.4K | ﹤0.01% |
3,027
+906
| +43% | +$35K |
|
1321
AtaiBeckley Inc
ATAI
$2.68B
| $72.2K | ﹤0.01% |
+17,649
| New | +$83.3K |
|
1322
Kodiak Sciences
KOD
$2.72B
| $72.1K | ﹤0.01% |
+2,578
| New | +$52.8K |
|
1323
Precigen
PGEN
$2.45B
| $71.9K | ﹤0.01% |
17,194
+5,674
| +49% | +$22K |
|
|
UPB
1324
Upstream Bio Inc
UPB
$378M
| $71.3K | ﹤0.01% |
+2,626
| New | +$65.4K |
|
|
ORKA
1325
Oruka Therapeutics
ORKA
$7.11B
| $71.3K | ﹤0.01% |
2,352
+904
| +62% | +$25.2K |
|
Similar funds
Mirae Asset Global Investments's Q4 2025 Portfolio in Review
As of Q4 2025, Mirae Asset Global Investments held 1,767 positions worth $36B, up 13% from $31.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mirae Asset Global Investments deployed $3.25B of net new capital in Q4 2025, opening 125 new positions and adding to 1,085 existing holdings. Its largest new stake was iShares Biotechnology ETF: 195,308 shares worth $33M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $61.1M trimmed.
- Mirae Asset Global Investments's largest Q4 2025 buy was iShares Biotechnology ETF: 195,308 shares worth $33M.
- Mirae Asset Global Investments added most to NVIDIA in Q4 2025, an estimated $315M increase.
- Mirae Asset Global Investments's biggest Q4 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $61.1M.
- Mirae Asset Global Investments fully exited Invesco Aerospace & Defense ETF in Q4 2025, selling an estimated $38.3M.
- Mirae Asset Global Investments's ten largest holdings make up 37% of its $36B portfolio in Q4 2025.
- Mirae Asset Global Investments opened 125 new positions and closed 124 in Q4 2025.
- Mirae Asset Global Investments's portfolio value rose 13% quarter-over-quarter to $36B.
Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.